Back

mTOR S-nitrosylation inhibits autophagy and lysosomal proteolysis

Tan, B. W. Q.; Tan, S.; Tan, B. W. L.; Navakkode, S.; Ng, C. Y.; Yuan, S.; Liang, M. C.; Liu, C.; Yin, S.; Chai, C.; Chew, K. C. M.; Tai, Y. K.; Sreedharan, S.; Lam, Y.; Liao, P.; Shen, H.-M.; Lim, K. L.; Wong, E.; Soong, T. W.

2020-09-11 cell biology
10.1101/2020.09.11.292607 bioRxiv
Show abstract

Mammalian Target of Rapamycin (mTOR) is a master regulator of autophagy and lysosomes, and its downstream kinase-dependent pathways have been extensively characterized. Here, we report an unexpected kinase-independent regulation of autophagy and lysosomes by S-nitrosylation at Cys423 position of mTOR that resulted in suppression of VPS34 and PIKfyve-dependent phosphoinositide synthesis. Physiologically, S-nitrosylation of mTOR reduced basal lysosomal proteolysis via nitric oxide synthase (NOS)-mediated synthesis of NO from lysosomal arginine precursor, a marker of cellular nutrition status. Significantly, we found increased lysosomal NOS-mTOR complexes in APP-PS1 Alzheimers disease (AD) murine model, and increased mTOR S-nitrosylation in AD patient-derived fibroblasts. Lastly, we demonstrated that pharmacological inhibition of NOS or overexpression of mTORCys423Ala mutant reversed lysosomal and autophagic dysfunction in AD patient-derived fibroblasts, suggesting novel therapeutic strategies for autophagosome-lysosomal activation.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.